Nea Management Company, LLC Genocea Biosciences, Inc. Transaction History

Nea Management Company, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.01 - $1.38 $103,769 - $14.3 Million	-10,376,936 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$1.81 - $5.53 $5.7 Million - $17.4 Million	3,151,260 Added 43.61%	10,376,936 $23.8 Million
Q1 2020 May 06, 2020	BUY	$1.26 - $2.73 $9.1 Million - $19.7 Million	7,225,676 New	7,225,676 $12.4 Million

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Nea Management Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Nea Management Company, LLC with notifications on news.